Hints and tips:
Related Special Reports
...That prompted Shionogi in late October to upgrade its annual guidance for domestic sales of Xocova, while it lowered its target for international sales....
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
...Its 12.5 per cent tax rate helped attract global tech and pharmaceutical companies and has led to bumper returns....
...In 2019 one of Asia’s three species, the tri-spine horseshoe crab, was listed as endangered by the International Union for Conservation of Nature....
...Even if the UK gets a stable government (one that doesn’t flip-flop on net zero or repeatedly threaten to legislate in defiance of its international treaty obligations) Brexit creates a permanent state of...
...The company also faces a $700mn arbitration process linked to its cancellation of a vaccine contract with Gavi, an international body providing vaccines to poor countries....
...PMI chief executive Jacek Olczak told the Financial Times that Vectura’s sales had suffered because of the reluctance of pharmaceutical partners to work with the company....
...Risk management Winner: Johnson & JohnsonOriginality: 8; Leadership: 9; Impact: 9; Total: 26The litigation team in Asia-Pacific designed a digital system for the pharmaceutical business to improve its management...
...The chief executive of the world’s largest tobacco group Philip Morris International is not short of anecdotes in which he implored people to quit smoking....
...The US pharmaceutical group on Tuesday issued the downbeat forecast despite reporting better than expected second-quarter sales, underlining the challenges faced by American multinationals in maintaining...
...Bausch & Lomb, the eyecare unit of the company formerly known as Valeant Pharmaceuticals, had been aiming to raise up to $840mn, on Thursday evening but eventually sold at $18 per share, raising $630mn....
...Worse, Bausch Health — formerly known as Valeant Pharmaceuticals — paid $2.4bn more for it back in 2013....
...But it still needs to complete an international phase 3 trial....
...Gabriel Harnier group general counsel, BAYER Three years ago, under Harnier’s leadership, the legal team at Bayer, the German pharmaceuticals and life sciences company, moved its contracting, data privacy...
...Visa and Mastercard play an important role in policing highly regulated, high-risk commerce such as gambling or pharmaceuticals, or other sectors prone to fraud....
...Public-health officials seem to envisage the end goal as a combination of improved pharmaceuticals and other measures that will minimise both infections and deaths....
...as a major shareholder of Valeant Pharmaceuticals....
...Drugmakers need to prioritise global access to Covid-19 vaccines and tie management pay to equitable distribution, a group of top international investors has said....
.... ©2021 Nikkei Inc....
...This week, the ICCR unveiled a suite of shareholder proposals that its members will put to Pfizer and other major pharmaceutical companies next year....
...Instead, Olczak said he was focused on expanding PMI’s “pharmaceutical and therapeutic” knowledge and suggested the group may move into the cannabidiol (CBD) market....
...A version of this article was first published by Nikkei Asia on July 22. ©2022 Nikkei Inc. All rights reserved....
...Its coronavirus jab “has a similar safety profile to other vaccines and the [European Medicines Agency] and other international bodies including the WHO, have all stated the benefits of vaccination continue...
...A potentially bigger opportunity is pharmaceuticals: a pre-IPO investment deck still available on the SpectrumX website says the company “holds licenses for both the UK and EU pharmaceutical application...
...A unit of a Japanese company backed by Philip Morris International is planning to launch the world’s first plant-based Covid-19 vaccine that is potentially cheaper and easier to transport and store than...
International Edition